Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology
Open Access
- 28 March 2017
- journal article
- research article
- Published by SAGE Publications in Tumor Biology
- Vol. 39 (3)
Abstract
The 4-1BB is a surface glycoprotein that pertains to the tumor necrosis factor–receptor family. There is compelling evidence suggesting important roles for 4-1BB in the immune response, including cell activation and proliferation and also cytokine induction. Because of encouraging results of different agonistic monoclonal antibodies against 4-1BB in the treatment of cancer, infectious, and autoimmune diseases, 4-1BB has been suggested as an attractive target for immunotherapy. In this study, single chain variable fragment phage display libraries, Tomlinson I+J, were screened against specific synthetic oligopeptides (peptides I and II) designed from 4-1BB extracellular domain. Five rounds of panning led to selection of four 4-1BB specific single chain variable fragments (PI.12, PI.42, PII.16, and PII.29) which showed specific reaction to relevant peptides in phage enzyme-linked immunosorbent assay. The selected clones were successfully expressed in Escherichia coli Rosetta-gami 2, and their expression was confirmed by western blot analysis. Enzyme-linked immunosorbent assay experiments indicated that these antibodies were able to specifically recognize 4-1BB without any cross-reactivity with other antigens. Flow cytometry analysis demonstrated an acceptable specific binding of the single chain variable fragments to 4-1BB expressed on CCRF-CEM cells, while no binding was observed with an irrelevant antibody. Anti-4-1BB single chain variable fragments enhanced surface CD69 expression and interleukin-2 production in stimulated CCRF-CEM cells which confirmed the agonistic effect of the selected single chain variable fragments. The data from this study have provided a rationale for further experiments involving the biological functions of anti-4-1BB single chain variable fragments in future studies.Keywords
This publication has 31 references indexed in Scilit:
- Immunotherapy of Cancer with 4-1BBMolecular Cancer Therapeutics, 2012
- 4-1BB signaling beyond T cellsCellular & Molecular Immunology, 2011
- The role of TNF superfamily members in T-cell function and diseasesNature Reviews Immunology, 2009
- Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapiesTrends in Pharmacological Sciences, 2008
- Expression and function of 4‐1BB during CD4 versus CD8 T cell responses in vivoEuropean Journal of Immunology, 2004
- Costimulation of T cells by OX40, 4-1BB, and CD27Cytokine & Growth Factor Reviews, 2003
- Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune diseaseNature Medicine, 2002
- 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cellsin vivo but does not contribute to the development of cytotoxicityEuropean Journal of Immunology, 2002
- Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell AnergyJournal of Experimental Medicine, 1999
- Role of 4-1BB in immune responsesSeminars in Immunology, 1998